Top

Inflammopharmacology

Published in:

01-08-2020 | Colchicine | Original Article

Effect of combined colchicine-corticosteroid treatment on neutrophil/lymphocyte ratio: a predictive marker in Behçet disease activity

Authors: Fatmazohra Djaballah-Ider, Chafia Touil-Boukoffa

Published in: Inflammopharmacology | Issue 4/2020

Abstract

Background and aims

Behçet’s disease (BD) is an auto-immune vasculitis, characterized by episodic inflammation of multiple organs. The neutrophil to lymphocyte ratio (NLR) is used as a marker of inflammation in several diseases nowadays. While nitric oxide (NO) seem to be involved in BD pathogenicity. Our study aims to investigate the NLR as an inflammatory marker of BD activity as well as to evaluate the relationship between the NO production and NLR in Algerian BD patients with different clinical manifestations before and under colchicine + corticosteroid treatment.

Methods

For this purpose, we evaluated the NLR as the ratio of neutrophil count to lymphocyte count in naïve and treated active BD patients with different clinical manifestations and in inactive ones. Furthermore, we assessed NO production by the Griess’ method in the same patients. Additionally, we evaluated in vivo interferon-γ (IFN-γ) and interleukin-4 (IL-4) levels using ELISA.

Results and discussion

Our results indicate that the NLR and nitrite levels were higher in naïve active BD patients. Interestingly, this high ratio and NO production differed according to the clinical manifestations and was associated with an increased risk of mucocutaneous and vascular involvement. Importantly, in treated BD patients NLR was higher in active patients especially in those with mucocutaneous involvement while increased nitrites levels were regardless of the clinical manifestations studied. Both NLR and NO production decreased in these treated active patients. In addition, IL-4 production differed according to the clinical manifestations studied contrary to the IFN-γ production.

Conclusion

Collectively our results suggest that the NLR is a potential marker of BD activity in Algerian patients, predicting the disease severity. Moreover, the positive relationship between the NLR and NO production is related to an increased risk of mucocutaneous lesions and vascular involvement. Thus, the application of these two accessible tools could be benefit for the clinical prognosis and treatment of BD.

Acikgoz N (2016) The neutrophil-lymphocyte ratio and behcet disease. Angiology 67(3):297. https://doi.org/10.1177/0003319715611805 CrossRefPubMed

Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M, Acarturk G (2013) As a new inflammatory marker for familial mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation 36(6):1357–1362. https://doi.org/10.1007/s10753-013-9675-2 CrossRefPubMed

Akkaya G, Bilen Ç (2019) Comments on: role of neutrophil-to-lymphocyte ratio as a prognostic indicator for hemodialysis arteriovenous fistula failure. J Vasc Access 20(6):788–789. https://doi.org/10.1177/1129729819874998 CrossRefPubMed

Akkurt ZM, Bozkurt M, Uçmak D, Yüksel H, Uçak H, Sula B, Özkurt ZG, Yildiz M, Akdeniz D, Arica M (2015) Serum cytokine levels in Behçet’s disease. J Clin Lab Anal 29(4):317–320. https://doi.org/10.1002/jcla.21772 CrossRefPubMed

Alan S, Tuna S, Türkoğlu EB (2015) The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behçet’s syndrome. Kaohsiung J Med Sci 31(12):626–631. https://doi.org/10.1016/j.kjms.2015.10.010 CrossRefPubMed

Aridogan BC, Yildirim M, Vahide Baysal H, Inaloz S, Baz K, Kaya S (2003) Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet’s disease. J Dermatol 30(8):602–607CrossRef

Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H (2017) Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics. J Dermatol 44(10):1112–1121. https://doi.org/10.1111/1346-8138.13875 CrossRefPubMed

Balkarli A, Kucuk A, Babur H, Erbasan F (2016) Neutrophil/lymphocyte ratio and mean platelet volume in Behçet’s disease. Eur Rev Med Pharmacol Sci 20(14):3045–3050PubMed

Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A (2016) The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thrombosis/Hemost Off J Int Acad Clin Appl Thrombosis/Hemost 22(5):405–411. https://doi.org/10.1177/1076029615569568 CrossRef

Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T (2013) Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 11(1):55–59. https://doi.org/10.1586/erc.12.159 CrossRefPubMed

Celikbilek M, Dogan S, Ozbakır O, Zararsız G, Kücük H, Gürsoy S, Yurci A, Güven K, Yücesoy M (2013) Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 27(1):72–76. https://doi.org/10.1002/jcla.21564 CrossRefPubMedPubMedCentral

Cetin A, Esin FC, Cefle A, Deniz G (2014) IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet’s disease. Mod Rheumatol 24(5):802–807. https://doi.org/10.3109/14397595.2013.879414 CrossRef

Cho S, Kim J, Cho SB, Zheng Z, Choi MJ, Kim DY, Bang D (2014) Immunopathogenic characterization of cutaneous inflammation in Behçet’s disease. J Eur Acad Dermatol Venereo JEADV 28(1):51–57. https://doi.org/10.1111/jdv.12054 CrossRef

International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335(8697):1078–1080

Demir S, Sag E, Dedeoglu F, Ozen S (2018) Vasculitis in systemic autoinflammatory diseases. Front Pediatr. https://doi.org/10.3389/fped.2018.00377 CrossRefPubMedPubMedCentral

Djaballah-Ider F, Chaib S, Belguendouz H, Talbi D, Touil-Boukoffa C et al (2012) T cells activation and interferon-γ/nitric oxide production during Behçet disease: a study in Algerian patients. Ocul Immunol Inflamm 20(3):215–217. https://doi.org/10.3109/09273948.2012.671882 CrossRefPubMed

Djaballah-Ider F, Djeraba Z, Chemli M, Dammene-Debbihe N, Lounis D, Belguendouz H, Medour Y, Chaib S, Touil-Boukoffa C (2018) Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet’s disease. Inflammopharmacology. https://doi.org/10.1007/s10787-018-0472-2 CrossRefPubMed

Djaballah-Ider F, Djaballah A, Djeraba Z, Chaib S, Touil-Boukoffa C (2019) Auto-immunity profile evaluation during different clinical manifestations of Behçet disease in Algerian patients: effect of corticosteroid treatment. Inflammopharmacol Février. https://doi.org/10.1007/s10787-019-00567-8 CrossRef

Djeraba Z, Boumedine K, Arroul-Lammali A, Otmani F, Belguendouz H, Touil-Boukoffa C (2014) Ex vivo immunomodulatory effect of all-trans-retinoic acid during Behçet’s disease: a study in Algerian patients. Immunopharmacol Immunotoxicol 36(1):78–86. https://doi.org/10.3109/08923973.2013.873048 CrossRefPubMed

Emmi G, Silvestri E, Della Bella C, Grassi A, Benagiano M, Cianchi F, Squatrito D et al (2016) Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease. Medicine. https://doi.org/10.1097/MD.0000000000005516 CrossRefPubMedPubMedCentral

Emmi G, Becatti M, Bettiol A, Hatemi G, Prisco D, Fiorillo C (2019) Behçet’s syndrome as a model of thrombo-inflammation: the role of neutrophils. Front Immunol. https://doi.org/10.3389/fimmu.2019.01085 CrossRefPubMedPubMedCentral

Erdağ E, Şahin C, Küçükali Cİ, Bireller S, Küçükerden M, Kürtüncü M, Türkoğlu R, Cakmakoglu B, Tüzün E, Arıcıoğlu F (2017) Effects of in vivo and in vitro administration of neuro-Behcet’s disease IgG. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 38(5):833–843. https://doi.org/10.1007/s10072-017-2856-2 CrossRef

Furuya MY, Temmoku J, Fujita Y, Matsuoka N, Asano T, Sato S, Kobayashi H, Watanabe H, Migita K (2019) Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT). Fukushima J Med Sci 65(2):55–60. https://doi.org/10.5387/fms.2019-07 CrossRefPubMedPubMedCentral

Gasparyan AY, Ayvazyan L, Yessirkepov M, Kitas GD (2015) Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol 11(11):1781–1794. https://doi.org/10.1517/17425255.2015.1076391 CrossRefPubMed

Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345. https://doi.org/10.3343/alm.2019.39.4.345 CrossRefPubMedPubMedCentral

Gholijani N, Ataollahi MR, Samiei A, Aflaki E, Shenavandeh S, Kamali-Sarvestani E (2017) An elevated pro-inflammatory cytokines profile in Behcet’s disease: a multiplex analysis. Immunol Lett 186:46–51. https://doi.org/10.1016/j.imlet.2016.12.001 CrossRefPubMed

Guenane H, Hartani D, Chachoua L, Lahlou-Boukoffa OS, Mazari F, Touil-Boukoffa C et al (2006) Production of Th1/Th2 cytokines and nitric oxide in Behçet’s uveitis and idiopathic uveitis. J Fr D’ophtalmologie 29(2):146–152CrossRef

Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol/Hematol 88(1):218–230. https://doi.org/10.1016/j.critrevonc.2013.03.010 CrossRef

Hammad M, Shehata OZ, Abdel-Latif SM, El-Din AMM (2018) Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet’s disease: which and when to use? Clin Rheumatol 37(10):2811–2817. https://doi.org/10.1007/s10067-018-4194-z CrossRefPubMed

Hamzaoui K (2011) Th17 cells in Behçet’s disease: a new immunoregulatory axis. Clin Exp Rheumatol 29(4 Suppl 67):S71–76PubMed

Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza MH, Ayed K (2002) Cytokine profile in Behçet’s disease patients. Relationship with disease activity. Scand J Rheumatol 31(4):205–210CrossRef

Hamzaoui A, Ghraïri H, Ammar J, Zekri S, Guemira F, Hamzaoui K (2003) IL-18 MRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet’s disease. Clin Exp Rheumatol 21(4 Suppl 30):S8–14PubMed

Horie Y, Meguro A, Ohta T, Lee EB, Namba K, Mizuuchi K, Iwata D et al (2017) HLA-B51 carriers are susceptible to ocular symptoms of Behçet disease and the association between the two becomes stronger towards the east along the silk road: a literature survey. Ocul Immunol Inflamm 25(1):37–40. https://doi.org/10.3109/09273948.2015.1136422 CrossRefPubMed

Inanir A, Tural S, Yigit S, Kalkan G, Pancar GS, Demir HD, Ates O (2013) Association of IL-4 gene VNTR variant with deep venous thrombosis in Behçet’s disease and its effect on ocular involvement. Mol Vis 19:675–683PubMedPubMedCentral

İşcan Y, Yiğit U, Tuğcu BÇ, Erdoğan M, Erdoğan DA, Öner V, Taş M, Özyazgan Y (2012) Tear nitric oxide levels in Behçet’s disease. Medicina (Kaunas, Lithuania) 48(11):559–562

Koarada S, Haruta Y, Tada Y, Ushiyama O, Morito F, Ohta A, Nagasawa K (2004) Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet’s disease. Rheumatol (Oxf Engl) 43(7):843–851. https://doi.org/10.1093/rheumatology/keh195 CrossRef

Leccese P, Alpsoy E (2019) Behçet’s disease: an overview of etiopathogenesis. Front Immunol. https://doi.org/10.3389/fimmu.2019.01067 CrossRefPubMedPubMedCentral

Merriman RC, Dissanayake O, Alnjar S, Burns F, Miller RF (2019) Incidence and significance of elevated platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios among hospitalised hiv-positive adult patients. Int J STD AIDS. https://doi.org/10.1177/0956462419868881 CrossRefPubMed

Murray NP, Fuentealba C, Reyes E, Lopez MA, Salazar A, Minzer S, Munoz L, Orrego S, Guzman E, Arzeno L (2019) Predictive value of neutrophil to lymphocyte ratio in the diagnosis of significant prostate cancer at initial biopsy: a comparison with free percent prostate specific antigen prostate specific antigen density and primary circulating prostate cells. Asian Pac J Cancer Prev 20(11):3385–3389. https://doi.org/10.31557/APJCP.2019.20.11.3385 CrossRefPubMedPubMedCentral

Na SY, Park M-J, Park S, Lee E-S (2013) Up-regulation of th17 and related cytokines in Behçet’s disease corresponding to disease activity. Clin Exp Rheumatol 31(3 Suppl 77):32–40PubMed

Neves FS, Spiller F (2013) Possible mechanisms of neutrophil activation in Behçet’s disease. Int Immunopharmacol 17(4):1206–1210. https://doi.org/10.1016/j.intimp.2013.07.017 CrossRefPubMed

Perazzio SF, PV Soeiro-Pereira, VC dos Santos, de Brito MV, Salu B, Vilela Oliva ML, Stevens AM et al (2017) Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet’s disease. PubMed NCBI. https://www.ncbi.nlm.nih.gov/pubmed/29052524

Rifaioglu EN, Şen BB, Ekiz Ö, Dogramaci AC (2014) Neutrophil to lymphocyte ratio in Behçet’s disease as a marker of disease activity. Acta Dermatovenerol Alp Pannon Adriat 23(4):65–67

Safi R, Kallas R, Bardawil T, Mehanna CJ, Abbas O, Hamam R, Uthman I, Kibbi A-G, Nassar D (2018) Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behçet’s disease. J Dermatol Sci 92(2):143–150. https://doi.org/10.1016/j.jdermsci.2018.08.010 CrossRefPubMed

Sanda GE, Belur AD, Teague HL, Mehta NN (2017) Emerging associations between neutrophils, atherosclerosis, and psoriasis. Curr Atheroscler Rep 19(12):53. https://doi.org/10.1007/s11883-017-0692-8 CrossRefPubMed

Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N (2014) Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol 33(3):223–227. https://doi.org/10.3109/15569527.2013.834498 CrossRefPubMed

Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F, Amirzargar A (2011) Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet’s disease. Clin Exp Rheumatol 29(4 Suppl 67):S28–31PubMed

Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Suzuki N (2012) Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet’s disease. Clin Exp Immunol 168(1):68–74. https://doi.org/10.1111/j.1365-2249.2011.04543.x CrossRefPubMedPubMedCentral

Sun JY, Mu N, Mu J, Zhang CG, Wang DM (2019) Significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with multiple myeloma. Zhongguo Shi Yan Xue Ye Xue Za Zhi 27(4):1185–1189. https://doi.org/10.19746/j.cnki.issn.1009-2137.2019.04.031 CrossRefPubMed

Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Behçet’s disease: a comprehensive review. J Autoimmun 64:137–148. https://doi.org/10.1016/j.jaut.2015.08.013 CrossRefPubMedPubMedCentral

Takeuchi M, Karasawa Y, Harimoto K, Tanaka A, Shibata M, Sato T, Caspi RR, Ito M (2017) Analysis of Th Cell-related cytokine production in Behçet disease patients with uveitis before and after infliximab treatment. Ocul Immunol Inflamm 25(1):52–61. https://doi.org/10.3109/09273948.2016.1158276 CrossRefPubMed

Talaat RM, Sibaii H, Bassyouni IH, El-Wakkad A (2019) IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet’s disease: correlation with clinical manifestations. Eur Cytokine Netw 30(1):15–22. https://doi.org/10.1684/ecn.2019.0421 CrossRefPubMed

Taysi S, Sari RA, Dursun H, Yilmaz A, Keles M, Cayir K, Akyuz M, Uyanik A, Guvenc A (2008) Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet’s disease. Clin Rheumatol 27(12):1529–1534. https://doi.org/10.1007/s10067-008-0963-4 CrossRefPubMed

Touil-Boukoffa C, Bauvois B, Sancéau J, Hamrioui B, Wietzerbin J (1998) Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie 80(8–9):739–744CrossRef

Trottier MD, Newsted MM, King LE, Fraker PJ (2008) Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc Natl Acad Sci USA 105(6):2028–2033. https://doi.org/10.1073/pnas.0712003105 CrossRefPubMed

Zeb A, Khurshid S, Bano S, Rasheed U, Zammurrad S, Khan MS, Aziz W, Tahir S (2019) The role of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as markers of disease activity in ankylosing spondylitis. Cureus 11(10):e6025. https://doi.org/10.7759/cureus.6025 CrossRefPubMedPubMedCentral

Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P (2016) Behçet’s disease physiopathology: a contemporary review. Auto Immun Highlights 7(1):4. https://doi.org/10.1007/s13317-016-0074-1 CrossRefPubMedPubMedCentral

Title: Effect of combined colchicine-corticosteroid treatment on neutrophil/lymphocyte ratio: a predictive marker in Behçet disease activity
Authors: Fatmazohra Djaballah-Ider
Chafia Touil-Boukoffa
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Colchicine
Angiography
Published in: Inflammopharmacology / Issue 4/2020
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-020-00701-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of combined colchicine-corticosteroid treatment on neutrophil/lymphocyte ratio: a predictive marker in Behçet disease activity

Abstract

Background and aims

Methods

Results and discussion

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background and aims

Methods

Results and discussion

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Marine sponges Sarcotragus foetidus, Xestospongia carbonaria and Spongia obscura constituents ameliorate IL-1 β and IL-6 in lipopolysaccharide-induced RAW 264.7 macrophages and carrageenan-induced oedema in rats

Retraction Note: Selected TLR7/8 agonist and type I interferon (IFN‑α) cooperatively redefine the microglia transcriptome

Evaluation of in vivo anti-inflammatory and anti-angiogenic attributes of methanolic extract of Launaea spinosa

Accelerated ageing profile in inflammatory arthritis is unique and tissue compartment specific

Correction to: Appraisal of disease-modifying potential of amlodipine as an anti-arthritic agent: new indication for an old drug

Significant action of Tridax procumbens L. leaf extract on reducing the TNF-α and COX-2 gene expressions in induced inflammation site in Swiss albino mice